Ysrafil Ysrafil
Overview
Explore the profile of Ysrafil Ysrafil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ysrafil Y, Imran A, Wicita P, Kamba V, Mohamad F, Ismail I, et al.
Bioimpacts
. 2025 Feb;
15:26443.
PMID: 39963556
Introduction: Presently, the development of effective vaccines against SARS-CoV-2 is absolutely necessary, especially regarding the emergence of new variants that cause increasing morbidity and fatalities. Methods: In the present study...
2.
Pratiwi S, Ysrafil Y, Mardhia M, Mahyarudin M, Ilmiawan M, Trianto H, et al.
Bioimpacts
. 2024 Sep;
14(5):27846.
PMID: 39296802
Introduction: The current vaccine strategies to prevent cervical cancer are effective only for individuals unexposed to HPV, lacking therapeutic effects against pre-existing infections. Multiepitope vaccines, using an immunoinformatic approach, are...
3.
Nugraha M, Changestu D, Ramadhan R, Salsabila T, Nurizati A, Pratiwi S, et al.
Osong Public Health Res Perspect
. 2024 Aug;
15(4):286-306.
PMID: 39091165
Background: Current tuberculosis (TB) control strategies face limitations, such as low antibiotic treatment compliance and a rise in multidrug resistance. Furthermore, the lack of a safe and effective vaccine compounds...
4.
Ryan N, Pratiwi S, Mardhia M, Ysrafil Y, Liana D, Mahyarudin M
Osong Public Health Res Perspect
. 2024 Jul;
15(4):307-328.
PMID: 39039819
Background: This study aimed to identify the optimal protein construction for designing a multi-epitope vaccine with both prophylactic and therapeutic effects against cervical cancer, utilizing an immunoinformatics approach. The construction...
5.
Ysrafil Y, Sapiun Z, Slamet N, Mohamad F, Hartati H, Damiti S, et al.
ADMET DMPK
. 2023 Oct;
11(3):331-359.
PMID: 37829324
Background And Purpose: Flavonoids are a group of phytochemicals found abundantly in various plants. Scientific evidence has revealed that flavonoids display potential biological activities, including their ability to alleviate inflammation....
6.
Ysrafil Y, Sapiun Z, Astuti I, Anasiru M, Slamet N, Hartati H, et al.
Bioimpacts
. 2022 Aug;
12(4):359-370.
PMID: 35975206
The current incidence of the novel coronavirus disease has shown only small reductions of cases and has become a major public health challenge. Development of effective vaccines against the virus...
7.
Putri R, Ysrafil Y, Awisarita W
Asian Pac J Cancer Prev
. 2022 Jun;
23(6):1817-1826.
PMID: 35763620
Background: There are more than 1,000 active volcanoes worldwide with inhabitants within 100 km of them. Volcanoes spill several toxic metals and spew pollution through gasses, causing soil and water...
8.
Ysrafil Y, Astuti I
Bioimpacts
. 2022 Jun;
12(3):195-202.
PMID: 35677668
MicroRNAs (miRNAs) are short-sequence RNAs that regulate gene expression by targeting messenger RNAs (mRNAs). Recent studies reveal that miRNA-324-5p plays an important role in worsening the ovarian cancer prognosis when...
9.
Emerging mutation in SARS-CoV-2 spike: Widening distribution over time in different geographic areas
Ysrafil Y, Mus R, Gama N, Rahmaisyah D, Nuramalia R
Biomed J
. 2021 Jul;
44(5):570-581.
PMID: 34271250
Background: Recently, differences in mortality rates of COVID-19 in different geographic areas have become an important subject of research because these different mortality rates appear to be associated with mutations...
10.
Ysrafil Y, Astuti I, Anwar S, Martien R, Sumadi F, Wardhana T, et al.
Adv Pharm Bull
. 2020 Oct;
10(4):630-637.
PMID: 33062603
Ovarian cancer is the most lethal of gynecological malignancies. Recently, the development of microRNA (miRNA) -based therapeutics that could impact broad cellular programs, leading to inhibition of cancer cell viability,...